# Policy 634: Leave Behind Naloxone

## I. Scope
A. To contribute to decreasing morbidity and mortality related to opioid overdose.

B. This standing order permits clinical and non-clinical staff who have completed Naloxone Training to distribute naloxone to eligible clients from CDPH-provided supplies. Restock of harm reduction naloxone will be through the EMS Innovator or Medic 100.

## II. Distribution

A. Eligible clients include any person at risk of experiencing an opioid-related drug overdose, or a family member, friend or other person able to assist a person at risk of experiencing an opioid-related drug overdose.

B. Assess the client who presents for contraindications and precautions, including:

### 1. Contraindications:
- Hypersensitivity or allergy to naloxone.

### 2. Precautions:
a) Anaphylactic shock may occur in those allergic to naloxone or any component of the medication.

b) Acute withdrawal symptoms may occur in individuals currently using opioids including: body aches, fever, sweating, runny nose, sneezing, yawning, weakness, shivering or trembling, nervousness, restlessness or irritability, diarrhea, nausea, abdominal cramps, increased blood pressure and tachycardia.

c) Persons, especially those with pre-existing cardiovascular disorders, should be closely monitored in an appropriate healthcare setting after receiving naloxone.

## III. Order

A. Document in ImageTrend on Narrative screen "Innovator Followup", then select "Narcan left on scene" from the dropdown menu.

B. Distribute as available one box (two naloxone 4 mg/0.1 ml) intranasal administration devices.

C. Offer all clients a copy of the Naloxone Fact Sheet (English or Spanish).

---

**David Ghilarducci MD**  
EMS Medical Director

Santa Cruz County EMS Agency Operational Policies - Section 600

